-
The Cochrane Infectious Diseases Group (CIDG), which has its editorial base at LSTM, helps prepare systematic reviews related to the diagnosis and treatment of tuberculosis. Ahead of World TB Day, this week welcomes the publication of a Special Collection on the Cochrane Library that tracks the development of exciting new diagnostic...
March 29 2019
-
Plain language summaryLinezolid for managing people with drug‐resistant tuberculosisWhat is drug‐resistant tuberculosis, and how might linezolid work?Tuberculosis is caused by infection with Mycobacterium tuberculosis bacteria. When there are symptoms or signs of illness, this is called active tuberculosis. An estimated one‐third of the...
March 20 2019
-
LSTM's Centre for Evidence Synthesis in Global Health has led developments in systematic reviews in tropical medicine and international health. In the 1990s, staff contributed to setting up Cochrane, and established the Cochrane Infectious Diseases Group (CIDG). This is now recognised as one of Cochrane's premier groups, with over 150 Cochrane...
March 19 2019
-
In this report, we meet Anel Schoonees, who works with the CIDG editorial base as an Information Specialist with a special focus on the HIV portfolio. Could you describe where you currently work and what you do there? Since 2009, I have been working at Stellenbosch University in Cape Town, South Africa. I am a researcher here at the...
March 8 2019
-
Details below on the latest submission to the Cochrane Database of Systematic Reviews Issue 2, 2019 from the Cochrane Infectious Diseases Group (reviews and protocols published 1 – 28 February).1 New ProtocolChoi L, Johnson S, Cunningham J, Takwoingi Y. Rapid diagnostic tests for Plasmodium vivax malaria in endemic...
March 8 2019
-
The World Health Organization published Guidelines for malaria vector control this week, drawing on seven Cochrane reviews specially prepared for them by the Cochrane Infectious Diseases Group (CIDG). With its editorial base at LSTM, CIDG was asked to review all of the evidence that was used in bringing together what WHO have described...
February 26 2019
-
A new Cochrane Library editorial has been published following the publication of a Cochrane review by Yotsu and colleagues which summarises the evidence of drug treatments for treating Buruli ulcer.The Cochrane Review describes the past decades of Buruli ulcer clinical chemotherapy research. It provides an important clinical research agenda, and...
February 18 2019
-
Researchers from LSTM have looked at the efficacy of using a novel artemisinin-based combination therapy (ACT), pyronaridine-artesunate, to treat malaria in areas where resistance to other ACTs is becoming a problem. The analysis finds it at least as effective as the currently used ACTs, if not better.The World Health Organization (WHO) recommends...
February 9 2019
-
Details below on the latest submission to the Cochrane Database of Systematic Reviews Issue 1 2019 from the Cochrane Infectious Diseases Group (reviews and protocols published 1 – 31 January).3 Updated reviews Gonzales MLM, Dans LF, Sio‐Aguilar J. Antiamoebic drugs for treating amoebic colitis. Cochrane Database of Systematic...
February 7 2019
-
Details below on the latest submission to the Cochrane Database of Systematic Reviews Issue 12, 2018 from the Cochrane Infectious Diseases Group (reviews and protocols published 1 – 31 December).1 New protocolAnton‐Vazquez V, Hine P, Krishna S, Richardson M, Planche T. Rapid versus standard antibiotic...
January 4 2019
The Cochrane Infectious Diseases Group (CIDG), which has its editorial base at LSTM, helps prepare systematic reviews related to the diagnosis and treatment of tuberculosis. Ahead of World TB Day, this week welcomes the publication of a Special Collection on the Cochrane Library that tracks the development of exciting new diagnostic...March 29 2019
Plain language summaryLinezolid for managing people with drug‐resistant tuberculosisWhat is drug‐resistant tuberculosis, and how might linezolid work?Tuberculosis is caused by infection with Mycobacterium tuberculosis bacteria. When there are symptoms or signs of illness, this is called active tuberculosis. An estimated one‐third of the...March 20 2019
LSTM's Centre for Evidence Synthesis in Global Health has led developments in systematic reviews in tropical medicine and international health. In the 1990s, staff contributed to setting up Cochrane, and established the Cochrane Infectious Diseases Group (CIDG). This is now recognised as one of Cochrane's premier groups, with over 150 Cochrane...March 19 2019
In this report, we meet Anel Schoonees, who works with the CIDG editorial base as an Information Specialist with a special focus on the HIV portfolio. Could you describe where you currently work and what you do there? Since 2009, I have been working at Stellenbosch University in Cape Town, South Africa. I am a researcher here at the...March 8 2019
Details below on the latest submission to the Cochrane Database of Systematic Reviews Issue 2, 2019 from the Cochrane Infectious Diseases Group (reviews and protocols published 1 – 28 February).1 New ProtocolChoi L, Johnson S, Cunningham J, Takwoingi Y. Rapid diagnostic tests for Plasmodium vivax malaria in endemic...March 8 2019
A new Cochrane Library editorial has been published following the publication of a Cochrane review by Yotsu and colleagues which summarises the evidence of drug treatments for treating Buruli ulcer.The Cochrane Review describes the past decades of Buruli ulcer clinical chemotherapy research. It provides an important clinical research agenda, and...February 18 2019
Researchers from LSTM have looked at the efficacy of using a novel artemisinin-based combination therapy (ACT), pyronaridine-artesunate, to treat malaria in areas where resistance to other ACTs is becoming a problem. The analysis finds it at least as effective as the currently used ACTs, if not better.The World Health Organization (WHO) recommends...February 9 2019